Fort Baker Capital (OACC) reports 5.1% ownership of Oaktree III
Rhea-AI Filing Summary
Oaktree Acquisition Corp. III Life Sciences ownership disclosure: Fort Baker Capital Management LP and affiliated reporting persons state they beneficially own 1,000,000 Class A ordinary shares, representing 5.1% of the class. The filing cites 19,783,010 shares outstanding as of March 26, 2026. The reported holdings reflect shared voting and shared dispositive power over 1,000,000 shares; sole voting and dispositive power are reported as 0. The reporting persons say they are filing jointly but disclaim membership in a group and disclaim beneficial ownership except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Major investor discloses a 5.1% stake in Oaktree Acquisition III.
The Schedule 13G shows Fort Baker Capital Management LP directly holds 1,000,000 Class A ordinary shares, equal to 5.1% of the class using the issuer's stated outstanding share count of 19,783,010 as of March 26, 2026. The position is reported with shared voting and dispositive power, which indicates control is exercised jointly rather than by a single holder.
Key dependencies are the issuer's outstanding-share figure and the reporting persons' joint-filing statements. Subsequent filings could show changes in ownership or voting arrangements; future Schedule 13D/13G amendments would disclose material shifts.
Filing emphasizes joint reporting and disclaimers of group membership and broader beneficial ownership.
The filing explicitly states the reporting persons "are filing this jointly, but not as members of a group" and that each "disclaims beneficial ownership of the securities reported herein except to the extent of that person's pecuniary interest therein." That language limits how these holdings are attributed for governance analysis.
For governance implications, note the reported shared voting power and shared dispositive power of 1,000,000 shares. Any changes in voting arrangements or additional acquisitions would be material and should appear in subsequent schedules.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficially owned regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.